Spen Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.70 Cr
as on 16-11-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.49 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.58 M
as on 16-11-2024
- Revenue 534.11%
(FY 2023)
- Profit -84.05%
(FY 2023)
- Ebitda -320.89%
(FY 2023)
- Net Worth 471.65%
(FY 2023)
- Total Assets 1555.00%
(FY 2023)
About Spen Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹2.49 Cr. The company has closed loans amounting to ₹5.58 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Maurya and Saksham Sangwan serve as directors at the Company.
- CIN/LLPIN
U45202HP2006PTC030153
- Company No.
030153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationH P, Himachal Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spen Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Maurya  | Additional Director | 23-May-2023 | Current |
| Saksham Sangwan | Additional Director | 17-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Spen Formulations.
Spen Formulations Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 534.11% increase. The company also saw a substantial fall in profitability, with a 84.05% decrease in profit. The company's net worth Soared by an impressive increase of 471.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spen Formulations?
Unlock access to Spen Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 02 Jul 2020 | ₹3.39 M | Open |
Karnataka Bank Ltd. Creation Date: 15 Jan 2008 | ₹2.15 Cr | Open |
Karnataka Bank Ltd. Creation Date: 25 May 2015 | ₹3.50 M | Satisfied |
How Many Employees Work at Spen Formulations?
Spen Formulations has a workforce of 14 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spen Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spen Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
